Sign In

Juan Benvenuto

Global Head, Cell & Gene Therapies Strategy & PMO at Novartis Oncology

Juan Benvenuto serves as the Global Head of Cell & Gene Therapies Strategy & PMO at Novartis Oncology. In this role, he is responsible for overseeing the strategic direction and project management office related to cell and gene therapies within the oncology division of Novartis, a leading global healthcare company.

While specific details about his career trajectory are not extensively documented in the available sources, it is known that he holds a significant position within Novartis, contributing to the company's efforts in advancing innovative treatments in oncology. His expertise likely encompasses strategic planning, project management, and collaboration across various teams to enhance the development and commercialization of cell and gene therapies.

For more detailed insights into his professional background or contributions, one might refer to his LinkedIn profile under the username jpbenve.

Highlights

May 24 · terrapinn.com
Amir Hefni | Advanced Therapies
Feb 1 · janssen.com
Oncology Leadership Team | Janssen

Related Questions

What are Juan Benvenuto's main responsibilities at Novartis Oncology?
How has Juan Benvenuto contributed to Novartis' immuno-oncology pipeline?
What is Juan Benvenuto's background before joining Novartis?
How does Juan Benvenuto's role impact the development of cell and gene therapies at Novartis?
What are some notable projects Juan Benvenuto has led at Novartis?
Juan Benvenuto
Add to my network

Location

New York City Metropolitan Area